STATE-OF-THE-ART OVARIAN CANCER CONFERENCE€¦ · STATE-OF-THE-ART OVARIAN CANCER CONFERENCE. COURSE FACULTY MSK FACULTY Jamie N. Bakkum-Gamez, MD Division of Gynecologic Oncology

STATE-OF-THE-ART

OVARIAN CANCER CONFERENCEOCTOBER 5, 2017Zuckerman Research Center417 East 68th Street New York, NY

Memorial Sloan Kettering Cancer Center presents the:

Advances in women’s health research provides important opportunities to enhance the screening and prevention of ovarian cancer. New modalities in the treatment of the disease provides the ability to individualize therapy, accomplish best clinical outcomes, and optimize the patient experience.

This course is composed of lectures and interactive audience participation encouraging the intellectual exchange of ideas between faculty and participants. Additionally, this year’s program will also feature new breakout sessions. The target audience includes all clinicians, scientists and advo-cates interested in women’s health, and in optimizing the pre-vention, screening and treatment for ovarian cancer. Clinicians including OB/GYNs, surgical/medical/gynecologic oncologists, primary care physicians, physician assistants, nurse practi-tioners, nurses, fellows and residents and other healthcare professionals are welcome.

EDUCATIONAL OBJECTIVES

• Discuss new genetic panel testing and its implication, results of recent ovarian cancer screening trial, and strategies for ovarian cancer risk-reduction.

• Present new algorithms for imaging and surgical case selection.

• Evaluate emerging opportunities in clinical trial options, individualized treatment, and enhanced patient experience.

MSK COURSE DIRECTORS

Ginger J. Gardner, MDAssociate Attending SurgeonPhysician Lead, Gynecology Disease

Management Team AllianceGynecology ServiceSection of Ovarian Cancer Surgery

Kara Long Roche, MD, MScAssistant Attending SurgeonGynecology ServiceSection of Ovarian Cancer Surgery

STATE-OF-THE-ARTOVARIAN CANCER CONFERENCE

COURSE FACULTY

MSK FACULTY

Jamie N. Bakkum-Gamez, MDDivision of Gynecologic OncologyDepartment of Obstetrics and GynecologyMayo Clinic

Jonathan A. Cosin, MDChief, Gynecologic OncologyThe Hospital of Central Connecticut

John Diaz, MD Gynecologic OncologyBaptist Health South Florida

Martin Martino, MDDivision of Gynecologic OncologyDepartment of Obstetrics and GynecologyLehigh Valley Physician Group

Pedro Ramirez, MDDirector of Minimally Invasive Surgical Research & EducationDepartment of Gynecologic OncologyMD Anderson Cancer Center

Anil Sood, MDProfessor and Vice Chair for

Translational ResearchDepartment of Gynecologic OncologyMD Anderson Cancer Center

Nadeem Abu-Rustum, MDChief, Gynecology ServiceVice Chair for Technology DevelopmentDepartment of SurgeryAvon Chair in Gynecologic Oncology

Carol Aghajanian, MDChief, Gynecologic Medical Oncology Service

Karen Cadoo, MDAssistant AttendingGynecologic Medical Oncology ServiceClinical Genetics Service

Jeanne Carter, PhDHead, Female Sexual MedicineAssociate Attending Psychologist

Dennis S. Chi, MDDeputy Chief and Head Section of

Ovarian Cancer SurgeryGynecology ServiceDepartment of Surgery

Deborah Goldfrank, MDHead, General Gynecology

Elizabeth Jewell, MDAssociate Attending Surgeon Gynecology ServiceDirector of SurgeryMSK Monmouth & MSK Basking Ridge

Yuliya Lakhman, MDAssociate Attending PhysicianGynecology Disease Management Team Department of Radiology

Stuart Lichtman, MDAttending PhysicanGynecologic Medical Oncology Service

Roisin E. O’Cearbhaill, MDAssistant Attending PhysicanGynecologic Medical Oncology Service

Paul Sabbatini, MDDeputy Physician-in-Chief for Clinical ResearchAttending PhysicianGynecologic Medical Oncology Service

Yukio Sonoda, MDAttending SurgeonGynecology ServiceSection of Ovarian Cancer Surgery

Robert Soslow, MDDirector Gynecologic PathologyDirector Gynecologic Pathology

Fellowship Program

David Spriggs, MDAttending PhysicanGynecologic Medical Oncology Service

William P. Tew, MDAssociate Attending PhysicianClinical Director, Gynecologic Medical Oncology

Dimitry Zamarin, MD, PhDAssistant Attending PhysicianGynecologic Medical Oncology Service

Oliver Zivanovic, MD, PhDAssistant Attending SurgeonDirector for Innovative Surgical TechnologyGynecology ServiceSection of Ovarian Cancer Surgery

VISITING FACULTY

7:30 am REGISTRATION AND BREAKFAST

8:00 am WelcomeNadeem Abu-Rustum, MDGinger J. Gardner, MD

8:15 am Section of Ovarian Cancer Surgery:Mission and Team OverviewDennis S. Chi, MD

SESSION IOVARIAN CANCER GENETICS, SCREENING AND PREVENTIONMODERATOR: Jonathan A. Cosin, MD

8:30 am Leveraging the Stress Response in Ovarian Cancer ManagementAnil Sood, MD

8:50 am New Genetic Risks:BRIP1, RAD51C, RAD51D and MoreKaren Cadoo, MD

9:10 am The Fallopian Tube and Ovarian Cancer DevelopmentRobert Soslow, MD

9:30 am Debate:Hysterectomy at Time of Risk-Reducing Salpingo-oophorectomy?Kara Long Roche, MD, MScMarty Martino, MD

9:50 am Discussion10:10 am BREAK

SESSION IIMANAGEMENT OF NEWLY DIAGNOSED OVARIAN CANCERMODERATOR: Ginger J. Gardner, MD

10:30 am MSK Resectability Scoring for Primary Debulking SurgeryYuliya Lakhman, MD

10:50 am Optimizing Upfront Debulking: Practical Applications and the Kaizen ApproachDennis S. Chi, MD

11:10 am Surgical Video:Radical Upper Abdominal Dissection

11:30 am Debate: Intraperitoneal Versus Weekly Intravenous Therapy for Newly Diagnosed Ovarian Cancer?Carol Aghajanian, MDPaul Sabbatini, MD

11:50 am Discussion12:00 pm LUNCH

SCIENTIFIC AGENDA

SESSION III BREAKOUT SESSIONS

Participants are able to attend the lectures of their choice from either session. Please note that you are free to move between sessions.

SESSION A: DEVELOPMENTS IN SYSTEMIC THERAPYMODERATOR: David Spriggs, MD

1:00 pm PARP Inhibitors: The Story ContinuesRoisin E. O’Cearbhaill, MD

1:20 pm New Strategies in ImmunotherapyDimitry Zamarin, MD, PhD

1:40 pm Debate:What is the Optimal Approach to the Aging Patient? Stuart Lichtman, MDWilliam P. Tew, MD

2:15 pm Discussion

2:30 pm BREAK

SESSION B:INNOVATIONS IN CARE AND THE PATIENT EXPERIENCEMODERATOR: Kara Long Roche, MD, MSc

1:00 pm Patient Reported Outcomes in Ovarian CancerElizabeth Jewell, MD

1:20 pm Vaginal Health and Sexual FunctionJeanne Carter, PhD

1:40 pm Robotic Approach to the Adnexal MassGinger J. Gardner, MD

2:00 pm Hormone Replacement Therapy in the Cancer PatientDeborah Goldfrank, MD

2:20 pm Discussion

2:30 pm BREAK

SCIENTIFIC AGENDA

SCIENTIFIC AGENDA

SESSION IVNEW FRONTIERSMODERATOR: John Diaz, MD

2:50 pm ERAS: Progressive Advances in Perioperative ManagementJamie N. Bakkum-Gamez, MD

3:10 pm ERAS Debate: To Bowel Prep or Not?...and Other Sticky IssuesYukio Sonoda, MDPedro Ramirez, MD

3:40 pm Surgery for Recurrent Disease: Palliative or Therapeutic IntentGinger J. Gardner, MD

4:00 pm HIPEC – Toxicity and OutcomesOliver Zivanovic, MD, PhD

4:30 pm NRG Updates and Highlights in Current Ovarian Cancer Clinical TrialsCarol Aghajanian, MD

4:50 pm Discussion5:00 pm CLOSING REMARKS & ADJOURN

Physicians (MDs, PhDs and DOs) $350

Residents, Fellows, RNs & Other Healthcare Providers $175

Industry Professionals* $800

REGISTER ONLINE:

www.mskcc.org/OvarianCourse

CONTINUING MEDICAL EDUCATIONMEMORIAL SLOAN KETTERING CANCER CENTER

633 Third Avenue, 12th Floor, New York, NY 10017w: www.mskcc.org/cme | e: [email protected]

/MSKCME @MSKCME MSK CME LinkedIn Group

REGISTRATION

Your registration fee includes course syllabus and other related handout materials, continental breakfast, lunch and refreshment breaks. Please contact CME at [email protected] at least one week prior to the course if you have any special dietary needs.

30% Discounted Rate for MSK Alumni and MSK Alliance Members MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for a promo code or more information.

MSK Staff Registration Registration is complimentary for MSK staff who wish to attend this course. However, you must register online by visiting the course website, www.mskcc.org/OvarianCourse.

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

ACCREDITATION STATEMENT MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT MSK designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

REGISTRATION FEES